Literature DB >> 12967067

Dental calculus composition following use of essential-oil/ZnCl2 mouthrinse.

Raquel Z LeGeros1, Ramin Rohanizadeh, Shujie Lin, Dindo Mijares, John P LeGeros, Christine H Charles, Pauline C Pan.   

Abstract

PURPOSE: To test the hypothesis that anticalculus agents cannot completely inhibit calculus formation but can influence the types of calcium phosphate which form, i.e., they can influence the composition of the inorganic component of human dental calculus (HDC).
MATERIALS AND METHODS: The composition of HDC specimens obtained from a 16-week multi-center clinical study using three regimens were analyzed, investigators blinded. The treatment regimens were: (a) standard dentifrice (SD), (b) pyrophosphate antitartar dentifrice, and (c) SD with Tartar Control Listerine Antiseptic mouthrinse (containing essential oils and 0.09% zinc chloride). 25 individual samples and eight pooled samples from each group were analyzed using X-ray diffraction, infrared spectroscopy, and scanning electron microscopy.
RESULTS: (1) relative frequency of occurrence for: (a) bacteria: Group A = 100%, Group B = 60%, and Group C = 25%; (b) Carbonate hydroxyapatite (CHA): Groups A, B, and C = 100%; (c) dicalcium phosphate dihydrate (DCPD): Group A = 55%; Group B = 45%; Group C = 80%; (2) The relative amount of DCPD is inversely proportional to that of CHA in HDC: the higher the amount of DCPD, the lower the amount of CHA. Group C regimen with essential oil/ZnCl2 mouthrinse and standard dentifrice showed a significant anti-microbial effect and favored the formation of DCPD, the most soluble Ca-P.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967067

Source DB:  PubMed          Journal:  Am J Dent        ISSN: 0894-8275            Impact factor:   1.522


  1 in total

1.  Penetration of an antimicrobial zinc-sugar alcohol complex into Streptococcus mutans biofilms.

Authors:  Jong Hyun Lim; Yongbeom Jeong; Sang-Hun Song; Jae-Hyun Ahn; Jeong Rae Lee; Sang-Min Lee
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.